iBio Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cover
- Document And Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Summary of Significant Accounting Policies (Policies)
Notes Tables
Notes Details
Uncategorized
- Insider Trading Arrangements

Stockholders' Equity (Wainwright Underwriting and Vesting of RSUs) (Details)

v3.24.1.1.u2

Stockholders' Equity (Wainwright Underwriting and Vesting of RSUs) (Details)		3 Months Ended
	Dec. 06, 2022 USD ($) D shares	Mar. 31, 2024 shares	Dec. 31, 2023 shares	Sep. 30, 2023 shares	Aug. 04, 2023 shares
Restricted Stock Units
Shares vested		20,409	4,951	4,467
Series A warrants
Warrants to purchase shares of Common Stock					173,795
Series B warrants
Warrants to purchase shares of Common Stock					102,900
H.C. Wainwright & Co., LLC [Member]
Warrants to purchase shares of Common Stock	10,096
Percentage of underwriting discount	7.00%
Number of days granted to purchase additional shares \| D	30
Additional shares issued	25,240
Warrants to purchase additional shares	50,480
Percentage of number of shares	6.00%
Net proceeds \| $	$ 2,864,000
H.C. Wainwright & Co., LLC [Member] \| Series A warrants
Warrants to purchase shares of Common Stock	25,240
H.C. Wainwright & Co., LLC [Member] \| Series B warrants
Warrants to purchase shares of Common Stock	25,240
H.C. Wainwright & Co., LLC [Member] \| Over-Allotment Option [Member]
Shares issued	76,538
H.C. Wainwright & Co., LLC [Member] \| Over-Allotment Option [Member] \| Pre Funded Warrants [Member]
Warrants to purchase shares of Common Stock	91,730
H.C. Wainwright & Co., LLC [Member] \| Over-Allotment Option [Member] \| Series A warrants
Warrants to purchase shares of Common Stock	168,269
H.C. Wainwright & Co., LLC [Member] \| Over-Allotment Option [Member] \| Series B warrants
Warrants to purchase shares of Common Stock	168,269

- Definition

Number of common warrants to purchase additional shares.

+ References

No definition available.

+ Details

Name:	ibio_CommonWarrantsToPurchaseAdditionalShares
Namespace Prefix:	ibio_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of additional shares issued.

+ References

No definition available.

+ Details

Name:	ibio_NumberOfAdditionalSharesIssued
Namespace Prefix:	ibio_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of days option to purchase additional shares.

+ References

No definition available.

+ Details

Name:	ibio_NumberOfDaysOptionToPurchaseAdditionalShares
Namespace Prefix:	ibio_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Percentage of aggregate number of shares of common stock.

+ References

No definition available.

+ Details

Name:	ibio_PercentageOfAggregateNumberOfSharesOfCommonStock
Namespace Prefix:	ibio_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Percentage of underwriting discount paid on gross proceeds of offering.

+ References

No definition available.

+ Details

Name:	ibio_PercentageOfUnderwritingDiscountPaidOnGrossProceedsOfOffering
Namespace Prefix:	ibio_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 14
-Subparagraph (a)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-14

+ Details

Name:	us-gaap_ProceedsFromIssuanceOfWarrants
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(02)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of new stock issued during the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-SubTopic 10
-Topic 505
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481004/946-505-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(4)(b))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-03(i)(1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=ibio_SeriesWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=ibio_SeriesBWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=ibio_H.c.WainwrightCo.LlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=ibio_PreFundedWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: